LOS ANGELES, June 6, 2018 /PRNewswire-PRWeb/ -- Drawbridge Health has been named as the winner of the "Best MedTech
Drawbridge Health is a privately-held healthcare technology company recently introduced by GE Ventures and GE Healthcare following an incubation period. Drawbridge Health is focused on reinventing the blood sampling paradigm, enabling more comfortable and convenient blood sample collection, anytime and anywhere. Drawbridge Health's proprietary technology is designed to integrate blood draw, collection and stabilization into a single device, with the goal of a more positive user experience and reduced logistical challenges associated with existing blood sampling methods.
Drawbridge Health's goal is to develop technologies that will broaden access to blood samples used for healthcare testing. Drawbridge has recently announced a strategic collaboration with Thorne Research in the U.S. health and wellness market.
"We are honored to be recognized as Best MedTech Startup in the prestigious MedTech Breakthrough Awards program," said Lee McCracken, CEO, Drawbridge Health. "We are developing an innovative blood sampling technology and our goal is to empower both healthcare providers and patient-consumers with better access to critical health information, so they can proactively monitor and address issues throughout the healthcare process. We truly appreciate this award from MedTech Breakthrough and the recognition of our team's passion for reinventing the blood sampling paradigm."
The mission of the MedTech Breakthrough Awards is to honor excellence and recognize the innovation, hard work and success in a range of health and medical technology categories, including Robotics, Clinical Administration, Telehealth, Patient Engagement, Electronic Health Records (EHR), mHealth, Medical Devices, Medical Data and many more. This year's program attracted more than 3,000 nominations from over 12 different countries throughout the world.
"This is great recognition for Drawbridge Health, a healthcare company that was incubated using technology from GE Healthcare and GE Global Research, and business model expertise from GE Business Innovations. Drawbridge Health is well positioned to transform diagnostic testing for healthcare stakeholders, testing laboratories, patients and consumers. We couldn't be more proud of the team," said Risa Stack, GM of Business Creation, GE Business Innovations.
"With the high volume of award nominations that came in for our 2018 MedTech Breakthrough Awards program, standing out from the pack to be selected as Best MedTech Startup is a notable achievement for Drawbridge Health," said James Johnson, managing director, MedTech Breakthrough. "Drawbridge Health embodies the spirit of the MedTech Breakthrough Awards program with ingenuity and standout technology that is simplifying one of the most frequent healthcare needs, providing a new way to collect and stabilize blood samples – efficiently, effectively and without the fear and discomfort associated with needles used for traditional blood collection."
GE shares technology, markets, structure and knowledge across its businesses to tackle industry challenges. Drawbridge Health combines technology from GE Global Research, expertise from GE Healthcare and business models from GE Ventures to develop a simple, safe and more efficient solution that can help save time, money and lives.
About MedTech Breakthrough The MedTech Breakthrough Awards program, part of the Tech Breakthrough Awards organization, is devoted to honoring excellence in medical and health related technology companies, products and people. The MedTech Breakthrough Awards provide a platform for public recognition around the achievements of breakthrough MedTech companies and products in categories including Patient Engagement, mHealth, Health & Fitness, Clinical Administration, Healthcare IoT, Genomics, Medical Data, Healthcare Cybersecurity and more. For more information visit http://www.MedTechBreakthrough.com.
About Drawbridge Health Drawbridge Health is focused on enabling personal diagnostic testing – anytime, anywhere. By integrating engineering and proprietary chemistries, Drawbridge is developing a people-friendly system for collecting and stabilizing blood samples, opening new doors to enable access to important health information. At Drawbridge Health, we're innovating new ways to put health in your hands. For more information, please visit http://www.drawbridgehealth.com.
SOURCE MedTech Breakthrough
Subscribe to our Free Newsletters!
Encephalocele is a birth defect where a sac like protrusion of brain and covering membranes occurs ...
Bronchopulmonary dysplasia or chronic lung disease of infancy is seen in premature and low birth ...
Ear, nose and throat are important organs and disease in one area can affect the others. ENT ...View All